06 . 05 .2020
Press release
Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
01 . 05 .2020
Press release
CETAPHIL by Galderma unites forces to focus on hand health and safety with their "In Good Hands" initiative to fight COVID-19
22 . 04 .2020
Press release
Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China
15 . 04 .2020
Press release
Galderma demonstrates continued commitment to aesthetic education by offering new series of digital webinars*
04 . 03 .2020
Press release
Galderma Announces an Acceleration of its Growth and Expansion Plans to Support Aesthetic Providers
03 . 03 .2020
Press release
Differin® Launches Clear90™ App, to Support People with Acne on Their Clear Skin Journey as Part of Third-Annual Retinoid Education Week
20 . 02 .2020
Press release
Galderma Announces New England Journal of Medicine Publication from Phase 2 Study of Investigational Therapy Nemolizumab in Patients with Moderate to Severe Prurigo Nodularis
20 . 12 .2019
Press release
Galderma receives a positive outcome through the European Decentralised Procedure for AKLIEF® (trifarotene 50 mcg/g cream), the first new retinoid molecule for acne in the European Union in 25 years
09 . 12 .2019
Press release
Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis